Industry Research Reports

Home > Reports > Pharma & Healthcare > Vinca Alkaloids Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Vinca Alkaloids Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-09

Pages: 98 Pages

Report ld: 3020287

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Vinca alkaloids, including vincristine, vinblastine and vinorelbine, are important anti-tumor agents and are widely used in the chemotherapy of various cancers. Vinca alkaloids can improve anti-tumor activity and reduce the toxicity of cancer cells, but few cases have shown that they cause clinically obvious acute liver injury.

The global market for Vinca Alkaloids Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Vinca Alkaloids Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Vinca Alkaloids Drugs by region & country, by Type, and by Application.

The Vinca Alkaloids Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vinca Alkaloids Drugs.

Market Segmentation

Report Metric
Details
Report Title
Vinca Alkaloids Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Vinca Alkaloids Drugs Companies Covered
Eli Lilly, Pfizer, Teva, Zhejiang Hisun Pharmaceutical Co., Ltd., Nippon Kayaku, Shenzhen Wanle Pharmaceutical Co., Ltd., Pierre Fabre, Jiangsu Haosen Pharmaceutical Group Co., Ltd., Luoxin Pharmaceutical Group Co., Ltd.
Global Vinca Alkaloids Drugs Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vinca Alkaloids Drugs Market, Segment by Type
Oncovin

Velban

Navelbine
Global Vinca Alkaloids Drugs Market, Segment by Application
Lymphoma

Sarcoma

Wimm's Tumor

Neuroblastoma

Breast Cancer

Lung Cancer

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Vinca Alkaloids Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Vinca Alkaloids Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Vinca Alkaloids Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Vinca Alkaloids Drugs Product Introduction
    1.2 Global Vinca Alkaloids Drugs Market Size Forecast
        1.2.1 Global Vinca Alkaloids Drugs Sales Value (2019-2030)
        1.2.2 Global Vinca Alkaloids Drugs Sales Volume (2019-2030)
        1.2.3 Global Vinca Alkaloids Drugs Sales Price (2019-2030)
    1.3 Vinca Alkaloids Drugs Market Trends & Drivers
        1.3.1 Vinca Alkaloids Drugs Industry Trends
        1.3.2 Vinca Alkaloids Drugs Market Drivers & Opportunity
        1.3.3 Vinca Alkaloids Drugs Market Challenges
        1.3.4 Vinca Alkaloids Drugs Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Vinca Alkaloids Drugs Players Revenue Ranking (2023)
    2.2 Global Vinca Alkaloids Drugs Revenue by Company (2019-2024)
    2.3 Global Vinca Alkaloids Drugs Players Sales Volume Ranking (2023)
    2.4 Global Vinca Alkaloids Drugs Sales Volume by Company Players (2019-2024)
    2.5 Global Vinca Alkaloids Drugs Average Price by Company (2019-2024)
    2.6 Key Manufacturers Vinca Alkaloids Drugs Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Vinca Alkaloids Drugs Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Vinca Alkaloids Drugs
    2.9 Vinca Alkaloids Drugs Market Competitive Analysis
        2.9.1 Vinca Alkaloids Drugs Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Vinca Alkaloids Drugs Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vinca Alkaloids Drugs as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Oncovin
        3.1.2 Velban
        3.1.3 Navelbine
    3.2 Global Vinca Alkaloids Drugs Sales Value by Type
        3.2.1 Global Vinca Alkaloids Drugs Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Vinca Alkaloids Drugs Sales Value, by Type (2019-2030)
        3.2.3 Global Vinca Alkaloids Drugs Sales Value, by Type (%) (2019-2030)
    3.3 Global Vinca Alkaloids Drugs Sales Volume by Type
        3.3.1 Global Vinca Alkaloids Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Vinca Alkaloids Drugs Sales Volume, by Type (2019-2030)
        3.3.3 Global Vinca Alkaloids Drugs Sales Volume, by Type (%) (2019-2030)
    3.4 Global Vinca Alkaloids Drugs Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Lymphoma
        4.1.2 Sarcoma
        4.1.3 Wimm's Tumor
        4.1.4 Neuroblastoma
        4.1.5 Breast Cancer
        4.1.6 Lung Cancer
        4.1.7 Other
    4.2 Global Vinca Alkaloids Drugs Sales Value by Application
        4.2.1 Global Vinca Alkaloids Drugs Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Vinca Alkaloids Drugs Sales Value, by Application (2019-2030)
        4.2.3 Global Vinca Alkaloids Drugs Sales Value, by Application (%) (2019-2030)
    4.3 Global Vinca Alkaloids Drugs Sales Volume by Application
        4.3.1 Global Vinca Alkaloids Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Vinca Alkaloids Drugs Sales Volume, by Application (2019-2030)
        4.3.3 Global Vinca Alkaloids Drugs Sales Volume, by Application (%) (2019-2030)
    4.4 Global Vinca Alkaloids Drugs Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Vinca Alkaloids Drugs Sales Value by Region
        5.1.1 Global Vinca Alkaloids Drugs Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Vinca Alkaloids Drugs Sales Value by Region (2019-2024)
        5.1.3 Global Vinca Alkaloids Drugs Sales Value by Region (2025-2030)
        5.1.4 Global Vinca Alkaloids Drugs Sales Value by Region (%), (2019-2030)
    5.2 Global Vinca Alkaloids Drugs Sales Volume by Region
        5.2.1 Global Vinca Alkaloids Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Vinca Alkaloids Drugs Sales Volume by Region (2019-2024)
        5.2.3 Global Vinca Alkaloids Drugs Sales Volume by Region (2025-2030)
        5.2.4 Global Vinca Alkaloids Drugs Sales Volume by Region (%), (2019-2030)
    5.3 Global Vinca Alkaloids Drugs Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Vinca Alkaloids Drugs Sales Value, 2019-2030
        5.4.2 North America Vinca Alkaloids Drugs Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Vinca Alkaloids Drugs Sales Value, 2019-2030
        5.5.2 Europe Vinca Alkaloids Drugs Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Vinca Alkaloids Drugs Sales Value, 2019-2030
        5.6.2 Asia Pacific Vinca Alkaloids Drugs Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Vinca Alkaloids Drugs Sales Value, 2019-2030
        5.7.2 South America Vinca Alkaloids Drugs Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Vinca Alkaloids Drugs Sales Value, 2019-2030
        5.8.2 Middle East & Africa Vinca Alkaloids Drugs Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Vinca Alkaloids Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Vinca Alkaloids Drugs Sales Value
        6.2.1 Key Countries/Regions Vinca Alkaloids Drugs Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Vinca Alkaloids Drugs Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Vinca Alkaloids Drugs Sales Value, 2019-2030
        6.3.2 United States Vinca Alkaloids Drugs Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Vinca Alkaloids Drugs Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Vinca Alkaloids Drugs Sales Value, 2019-2030
        6.4.2 Europe Vinca Alkaloids Drugs Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Vinca Alkaloids Drugs Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Vinca Alkaloids Drugs Sales Value, 2019-2030
        6.5.2 China Vinca Alkaloids Drugs Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Vinca Alkaloids Drugs Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Vinca Alkaloids Drugs Sales Value, 2019-2030
        6.6.2 Japan Vinca Alkaloids Drugs Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Vinca Alkaloids Drugs Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Vinca Alkaloids Drugs Sales Value, 2019-2030
        6.7.2 South Korea Vinca Alkaloids Drugs Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Vinca Alkaloids Drugs Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Vinca Alkaloids Drugs Sales Value, 2019-2030
        6.8.2 Southeast Asia Vinca Alkaloids Drugs Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Vinca Alkaloids Drugs Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Vinca Alkaloids Drugs Sales Value, 2019-2030
        6.9.2 India Vinca Alkaloids Drugs Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Vinca Alkaloids Drugs Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Eli Lilly
        7.1.1 Eli Lilly Company Information
        7.1.2 Eli Lilly Introduction and Business Overview
        7.1.3 Eli Lilly Vinca Alkaloids Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Eli Lilly Vinca Alkaloids Drugs Product Offerings
        7.1.5 Eli Lilly Recent Development
    7.2 Pfizer
        7.2.1 Pfizer Company Information
        7.2.2 Pfizer Introduction and Business Overview
        7.2.3 Pfizer Vinca Alkaloids Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Pfizer Vinca Alkaloids Drugs Product Offerings
        7.2.5 Pfizer Recent Development
    7.3 Teva
        7.3.1 Teva Company Information
        7.3.2 Teva Introduction and Business Overview
        7.3.3 Teva Vinca Alkaloids Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Teva Vinca Alkaloids Drugs Product Offerings
        7.3.5 Teva Recent Development
    7.4 Zhejiang Hisun Pharmaceutical Co., Ltd.
        7.4.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
        7.4.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Introduction and Business Overview
        7.4.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Vinca Alkaloids Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Vinca Alkaloids Drugs Product Offerings
        7.4.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development
    7.5 Nippon Kayaku
        7.5.1 Nippon Kayaku Company Information
        7.5.2 Nippon Kayaku Introduction and Business Overview
        7.5.3 Nippon Kayaku Vinca Alkaloids Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Nippon Kayaku Vinca Alkaloids Drugs Product Offerings
        7.5.5 Nippon Kayaku Recent Development
    7.6 Shenzhen Wanle Pharmaceutical Co., Ltd.
        7.6.1 Shenzhen Wanle Pharmaceutical Co., Ltd. Company Information
        7.6.2 Shenzhen Wanle Pharmaceutical Co., Ltd. Introduction and Business Overview
        7.6.3 Shenzhen Wanle Pharmaceutical Co., Ltd. Vinca Alkaloids Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Shenzhen Wanle Pharmaceutical Co., Ltd. Vinca Alkaloids Drugs Product Offerings
        7.6.5 Shenzhen Wanle Pharmaceutical Co., Ltd. Recent Development
    7.7 Pierre Fabre
        7.7.1 Pierre Fabre Company Information
        7.7.2 Pierre Fabre Introduction and Business Overview
        7.7.3 Pierre Fabre Vinca Alkaloids Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Pierre Fabre Vinca Alkaloids Drugs Product Offerings
        7.7.5 Pierre Fabre Recent Development
    7.8 Jiangsu Haosen Pharmaceutical Group Co., Ltd.
        7.8.1 Jiangsu Haosen Pharmaceutical Group Co., Ltd. Company Information
        7.8.2 Jiangsu Haosen Pharmaceutical Group Co., Ltd. Introduction and Business Overview
        7.8.3 Jiangsu Haosen Pharmaceutical Group Co., Ltd. Vinca Alkaloids Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Jiangsu Haosen Pharmaceutical Group Co., Ltd. Vinca Alkaloids Drugs Product Offerings
        7.8.5 Jiangsu Haosen Pharmaceutical Group Co., Ltd. Recent Development
    7.9 Luoxin Pharmaceutical Group Co., Ltd.
        7.9.1 Luoxin Pharmaceutical Group Co., Ltd. Company Information
        7.9.2 Luoxin Pharmaceutical Group Co., Ltd. Introduction and Business Overview
        7.9.3 Luoxin Pharmaceutical Group Co., Ltd. Vinca Alkaloids Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Luoxin Pharmaceutical Group Co., Ltd. Vinca Alkaloids Drugs Product Offerings
        7.9.5 Luoxin Pharmaceutical Group Co., Ltd. Recent Development

 8 Industry Chain Analysis
    8.1 Vinca Alkaloids Drugs Industrial Chain
    8.2 Vinca Alkaloids Drugs Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Vinca Alkaloids Drugs Sales Model
        8.5.2 Sales Channel
        8.5.3 Vinca Alkaloids Drugs Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Vinca Alkaloids Drugs Market Trends
    Table 2. Vinca Alkaloids Drugs Market Drivers & Opportunity
    Table 3. Vinca Alkaloids Drugs Market Challenges
    Table 4. Vinca Alkaloids Drugs Market Restraints
    Table 5. Global Vinca Alkaloids Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Vinca Alkaloids Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Vinca Alkaloids Drugs Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Vinca Alkaloids Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Vinca Alkaloids Drugs Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Vinca Alkaloids Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Vinca Alkaloids Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Vinca Alkaloids Drugs
    Table 13. Global Vinca Alkaloids Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vinca Alkaloids Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Vinca Alkaloids Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Vinca Alkaloids Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Vinca Alkaloids Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Vinca Alkaloids Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Vinca Alkaloids Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Vinca Alkaloids Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Vinca Alkaloids Drugs Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Vinca Alkaloids Drugs Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Vinca Alkaloids Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Vinca Alkaloids Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Vinca Alkaloids Drugs Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Vinca Alkaloids Drugs Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Vinca Alkaloids Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Vinca Alkaloids Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Vinca Alkaloids Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Vinca Alkaloids Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Vinca Alkaloids Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Vinca Alkaloids Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Vinca Alkaloids Drugs Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Vinca Alkaloids Drugs Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Vinca Alkaloids Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Vinca Alkaloids Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Vinca Alkaloids Drugs Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Vinca Alkaloids Drugs Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Vinca Alkaloids Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Vinca Alkaloids Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Vinca Alkaloids Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Vinca Alkaloids Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Vinca Alkaloids Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Vinca Alkaloids Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Vinca Alkaloids Drugs Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Vinca Alkaloids Drugs Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Vinca Alkaloids Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Vinca Alkaloids Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Vinca Alkaloids Drugs Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Vinca Alkaloids Drugs Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Vinca Alkaloids Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Vinca Alkaloids Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Vinca Alkaloids Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Vinca Alkaloids Drugs Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Vinca Alkaloids Drugs Sales Volume, (2025-2030) & (K Units)
    Table 57. Eli Lilly Company Information
    Table 58. Eli Lilly Introduction and Business Overview
    Table 59. Eli Lilly Vinca Alkaloids Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Eli Lilly Vinca Alkaloids Drugs Product Offerings
    Table 61. Eli Lilly Recent Development
    Table 62. Pfizer Company Information
    Table 63. Pfizer Introduction and Business Overview
    Table 64. Pfizer Vinca Alkaloids Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Pfizer Vinca Alkaloids Drugs Product Offerings
    Table 66. Pfizer Recent Development
    Table 67. Teva Company Information
    Table 68. Teva Introduction and Business Overview
    Table 69. Teva Vinca Alkaloids Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Teva Vinca Alkaloids Drugs Product Offerings
    Table 71. Teva Recent Development
    Table 72. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
    Table 73. Zhejiang Hisun Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 74. Zhejiang Hisun Pharmaceutical Co., Ltd. Vinca Alkaloids Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Zhejiang Hisun Pharmaceutical Co., Ltd. Vinca Alkaloids Drugs Product Offerings
    Table 76. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development
    Table 77. Nippon Kayaku Company Information
    Table 78. Nippon Kayaku Introduction and Business Overview
    Table 79. Nippon Kayaku Vinca Alkaloids Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Nippon Kayaku Vinca Alkaloids Drugs Product Offerings
    Table 81. Nippon Kayaku Recent Development
    Table 82. Shenzhen Wanle Pharmaceutical Co., Ltd. Company Information
    Table 83. Shenzhen Wanle Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 84. Shenzhen Wanle Pharmaceutical Co., Ltd. Vinca Alkaloids Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Shenzhen Wanle Pharmaceutical Co., Ltd. Vinca Alkaloids Drugs Product Offerings
    Table 86. Shenzhen Wanle Pharmaceutical Co., Ltd. Recent Development
    Table 87. Pierre Fabre Company Information
    Table 88. Pierre Fabre Introduction and Business Overview
    Table 89. Pierre Fabre Vinca Alkaloids Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Pierre Fabre Vinca Alkaloids Drugs Product Offerings
    Table 91. Pierre Fabre Recent Development
    Table 92. Jiangsu Haosen Pharmaceutical Group Co., Ltd. Company Information
    Table 93. Jiangsu Haosen Pharmaceutical Group Co., Ltd. Introduction and Business Overview
    Table 94. Jiangsu Haosen Pharmaceutical Group Co., Ltd. Vinca Alkaloids Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Jiangsu Haosen Pharmaceutical Group Co., Ltd. Vinca Alkaloids Drugs Product Offerings
    Table 96. Jiangsu Haosen Pharmaceutical Group Co., Ltd. Recent Development
    Table 97. Luoxin Pharmaceutical Group Co., Ltd. Company Information
    Table 98. Luoxin Pharmaceutical Group Co., Ltd. Introduction and Business Overview
    Table 99. Luoxin Pharmaceutical Group Co., Ltd. Vinca Alkaloids Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Luoxin Pharmaceutical Group Co., Ltd. Vinca Alkaloids Drugs Product Offerings
    Table 101. Luoxin Pharmaceutical Group Co., Ltd. Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Vinca Alkaloids Drugs Downstream Customers
    Table 105. Vinca Alkaloids Drugs Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vinca Alkaloids Drugs Product Picture
    Figure 2. Global Vinca Alkaloids Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Vinca Alkaloids Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Vinca Alkaloids Drugs Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Vinca Alkaloids Drugs Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Vinca Alkaloids Drugs Report Years Considered
    Figure 7. Global Vinca Alkaloids Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Vinca Alkaloids Drugs Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Vinca Alkaloids Drugs Revenue in 2023
    Figure 10. Vinca Alkaloids Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Oncovin Picture
    Figure 12. Velban Picture
    Figure 13. Navelbine Picture
    Figure 14. Global Vinca Alkaloids Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Vinca Alkaloids Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Vinca Alkaloids Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Vinca Alkaloids Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Vinca Alkaloids Drugs Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Lymphoma
    Figure 20. Product Picture of Sarcoma
    Figure 21. Product Picture of Wimm's Tumor
    Figure 22. Product Picture of Neuroblastoma
    Figure 23. Product Picture of Breast Cancer
    Figure 24. Product Picture of Lung Cancer
    Figure 25. Product Picture of Other
    Figure 26. Global Vinca Alkaloids Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 27. Global Vinca Alkaloids Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 28. Global Vinca Alkaloids Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 29. Global Vinca Alkaloids Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 30. Global Vinca Alkaloids Drugs Price by Application (2019-2030) & (US$/Unit)
    Figure 31. North America Vinca Alkaloids Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 32. North America Vinca Alkaloids Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 33. Europe Vinca Alkaloids Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 34. Europe Vinca Alkaloids Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 35. Asia Pacific Vinca Alkaloids Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 36. Asia Pacific Vinca Alkaloids Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 37. South America Vinca Alkaloids Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 38. South America Vinca Alkaloids Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 39. Middle East & Africa Vinca Alkaloids Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 40. Middle East & Africa Vinca Alkaloids Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 41. Key Countries/Regions Vinca Alkaloids Drugs Sales Value (%), (2019-2030)
    Figure 42. Key Countries/Regions Vinca Alkaloids Drugs Sales Volume (%), (2019-2030)
    Figure 43. United States Vinca Alkaloids Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 44. United States Vinca Alkaloids Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 45. United States Vinca Alkaloids Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 46. Europe Vinca Alkaloids Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Europe Vinca Alkaloids Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 48. Europe Vinca Alkaloids Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 49. China Vinca Alkaloids Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 50. China Vinca Alkaloids Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 51. China Vinca Alkaloids Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 52. Japan Vinca Alkaloids Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Japan Vinca Alkaloids Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 54. Japan Vinca Alkaloids Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 55. South Korea Vinca Alkaloids Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 56. South Korea Vinca Alkaloids Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 57. South Korea Vinca Alkaloids Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 58. Southeast Asia Vinca Alkaloids Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 59. Southeast Asia Vinca Alkaloids Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 60. Southeast Asia Vinca Alkaloids Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 61. India Vinca Alkaloids Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 62. India Vinca Alkaloids Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 63. India Vinca Alkaloids Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 64. Vinca Alkaloids Drugs Industrial Chain
    Figure 65. Vinca Alkaloids Drugs Manufacturing Cost Structure
    Figure 66. Channels of Distribution (Direct Sales, and Distribution)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed

Description

Vinca alkaloids, including vincristine, vinblastine and vinorelbine, are important anti-tumor agents and are widely used in the chemotherapy of various cancers. Vinca alkaloids can improve anti-tumor activity and reduce the toxicity of cancer cells, but few cases have shown that they cause clinically obvious acute liver injury.

The global market for Vinca Alkaloids Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

Market Segmentation